Molecular Pediatric Oncology
1 – 39 of 39
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
- 2023
-
Mark
Therapeutic strategies for high-risk neuroblastoma
2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Unconventional Source of Neurotoxic Protein Aggregation from Organelle Off-Target Bax∆2 in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Macrophage infiltration promotes regrowth in MYCN-amplified neuroblastoma after chemotherapy
(
- Contribution to journal › Article
-
Mark
Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
(
- Contribution to journal › Article
-
Mark
Patient-derived models : Advanced tools for precision medicine in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Gene expression in metastatic breast cancer—patterns in primary tumors and metastatic tissue with prognostic potential
(
- Contribution to journal › Article
- 2022
-
Mark
Clinically relevant treatment of PDX models reveals patterns of neuroblastoma chemoresistance
(
- Contribution to journal › Article
-
Mark
Engineering human mini-bones for the standardized modeling of healthy hematopoiesis, leukemia, and solid tumor metastasis
(
- Contribution to journal › Article
- 2021
-
Mark
Inhibition of fatty acid synthesis induces differentiation and reduces tumor burden in childhood neuroblastoma
(
- Contribution to journal › Article
-
Mark
Label-free separation of neuroblastoma patient-derived xenograft (PDX) cells from hematopoietic progenitor cell products by acoustophoresis
(
- Contribution to journal › Article
-
Mark
Pam50 intrinsic subtype profiles in primary and metastatic breast cancer show a significant shift toward more aggressive subtypes with prognostic implications
(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
(
- Contribution to journal › Article
- 2020
-
Mark
Expression of epithelial-mesenchymal transition-related markers and phenotypes during breast cancer progression
(
- Contribution to journal › Article
-
Mark
Evolution of estrogen receptor status from primary tumors to metastasis and serially collected circulating tumor cells
(
- Contribution to journal › Article
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Integrative discovery of treatments for high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Inflammatory macrophage derived TNFα downregulates estrogen receptor α via FOXO3a inactivation in human breast cancer cells
(
- Contribution to journal › Article
-
Mark
Complement inhibitor factor H expressed by breast cancer cells differentiates CD14+ human monocytes into immunosuppressive macrophages
(
- Contribution to journal › Article
-
Mark
Serial evaluation of serum thymidine kinase activity is prognostic in women with newly diagnosed metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
(
- Contribution to journal › Article
-
Mark
Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
(
- Contribution to journal › Article
-
Mark
Preclinical investigation of novel therapies against neuroblastoma
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
The distribution of circulating tumor cells is different in metastatic lobular compared to ductal carcinoma of the breast –long term prognostic significant
(
- Contribution to journal › Article
-
Mark
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
(
- Contribution to journal › Article
- 2019
-
Mark
The Iroquois homeobox proteins IRX3 and IRX5 have distinct roles in Wilms tumour development and human nephrogenesis
(
- Contribution to journal › Article
-
Mark
Detection of circulating tumor cells and circulating tumor DNA before and after mammographic breast compression in a cohort of breast cancer patients scheduled for neoadjuvant treatment
(
- Contribution to journal › Article
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article
- 2018
-
Mark
Patient-derived xenografts as preclinical neuroblastoma models
(
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
(
- Contribution to journal › Article
- 2017
-
Mark
Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum
(
- Contribution to journal › Article
-
Mark
Patient-derived xenografts as preclinical models of neuroblastoma
2017)(
- Thesis › Doctoral thesis (compilation)
- 2016
-
Mark
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
(
- Contribution to journal › Scientific review
-
Mark
Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours
(
- Contribution to journal › Article
- 2015
-
Mark
Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer.
(
- Contribution to journal › Article
-
Mark
PI3K-mTORC2 but not PI3K-mTORC1 Regulates Transcription of HIF2A/EPAS1 and Vascularization in Neuroblastoma.
(
- Contribution to journal › Article
-
Mark
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
(
- Contribution to journal › Article
-
Mark
Neuroblastoma Patient-Derived Orthotopic Xenografts Retain Metastatic Patterns and Geno- and Phenotypes of Patient Tumours.
(
- Contribution to journal › Article